Watchlist Price Alert

Acorda Therapeutics Inc. (ACOR)

NASDAQ: ACOR · Real-Time Price · USD

0.66

-0.21 (-24.14%)

At close: Apr 03, 2024, 3:59 PM

Acorda Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-252.85M	-65.92M	-103.95M	-99.59M	-272.97M	33.68M	-223.36M	-35.6M
Depreciation & Amortization	31.67M	32.81M	33.95M	41.3M	34.57M	11.48M	23.23M	21.58M
Stock-Based Compensation	478K	1.49M	3M	8.1M	14.25M	21.25M	32.81M	36.39M
Other Working Capital	-4.88M	676K	12.78M	-1.42M	14.02M	-15.32M	15K	4.23M
Other Non-Cash Items	260.73M	-21.68M	5.91M	-3.52M	139.36M	51.28M	345.02M	8.94M
Deferred Income Tax	-43.18M	30.67M	-5.19M	4.67M	-1.98M	-14.51M	-54.04M	-11.19M
Change in Working Capital	-10.83M	1.7M	24.93M	-11.95M	-41.41M	47.61M	-27.16M	15.23M
Operating Cash Flow	-13.98M	-20.92M	-41.35M	-61.01M	-128.17M	150.79M	96.5M	35.35M
Capital Expenditures	-264K	-136K	-191K	-4.39M	-90.43M	-33.91M	-14.38M	-273.54M
Cash Acquisitions	n/a	n/a	73.97M	n/a	-89.92M	587K	n/a	-267.35M
Purchase of Investments	n/a	n/a	n/a	n/a	-226.59M	-249.11M	n/a	-40.22M
Sales Maturities Of Investments	n/a	n/a	n/a	63.75M	316.51M	98.27M	n/a	239.97M
Other Investing Acitivies	n/a	n/a	73.94M	63.75M	89.92M	7.3M	3.66M	267.35M
Investing Cash Flow	-264K	-136K	73.78M	59.36M	-505K	-176.87M	-10.71M	-73.79M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-91K	-1.74M	-60K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-63.93M	n/a	n/a
Other Financial Acitivies	n/a	n/a	-69.66M	-1.67M	-60.55M	76.72M	61.52M	45.93M
Financial Cash Flow	n/a	n/a	-69.66M	-1.67M	-60.55M	12.8M	61.52M	45.93M
Net Cash Flow	-14.06M	-20.55M	-37.67M	-2.3M	-189.16M	-13.69M	148.53M	5.33M
Free Cash Flow	-14.25M	-21.06M	-41.54M	-65.4M	-218.59M	116.88M	82.12M	-238.19M